Melanoma Diagnostics and Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: M91A6A8741D8EN
Market Monitor Global

Abstracts

Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. The market for melanoma diagnostics and therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities.

This report contains market size and forecasts of Melanoma Diagnostics and Therapeutics in Global, including the following market information:

Global Melanoma Diagnostics and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Melanoma Diagnostics and Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Nodular Melanoma Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Melanoma Diagnostics and Therapeutics include Abbott, Agilent Technologies, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Melanoma Diagnostics and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Melanoma Diagnostics and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Melanoma Diagnostics and Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Nodular Melanoma
• Superficial Spreading Melanoma
• Amelanotic Melanoma
• Others

Global Melanoma Diagnostics and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Melanoma Diagnostics and Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Diagnostic Center
• Medical Institution
• Others

Global Melanoma Diagnostics and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Melanoma Diagnostics and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Melanoma Diagnostics and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Melanoma Diagnostics and Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Agilent Technologies
• AstraZeneca
• Bristol-Myers Squibb
• Eli Lilly
• GlaxoSmithKline
• Merck
• Novartis
• Pfizer
• Qiagen
• Roche
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Melanoma Diagnostics and Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Melanoma Diagnostics and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MELANOMA DIAGNOSTICS AND THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Melanoma Diagnostics and Therapeutics Market Size: 2021 VS 2028
2.2 Global Melanoma Diagnostics and Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Melanoma Diagnostics and Therapeutics Players in Global Market
3.2 Top Global Melanoma Diagnostics and Therapeutics Companies Ranked by Revenue
3.3 Global Melanoma Diagnostics and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Melanoma Diagnostics and Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Melanoma Diagnostics and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Melanoma Diagnostics and Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Melanoma Diagnostics and Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Melanoma Diagnostics and Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Melanoma Diagnostics and Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Nodular Melanoma
  4.1.3 Superficial Spreading Melanoma
  4.1.4 Amelanotic Melanoma
  4.1.5 Others
4.2 By Type - Global Melanoma Diagnostics and Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Melanoma Diagnostics and Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Melanoma Diagnostics and Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Melanoma Diagnostics and Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Diagnostic Center
  5.1.4 Medical Institution
  5.1.5 Others
5.2 By Application - Global Melanoma Diagnostics and Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Melanoma Diagnostics and Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Melanoma Diagnostics and Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Melanoma Diagnostics and Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Melanoma Diagnostics and Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Melanoma Diagnostics and Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Melanoma Diagnostics and Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
  6.3.2 US Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.3.3 Canada Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
  6.4.2 Germany Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.3 France Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.5 Italy Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.6 Russia Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
  6.5.2 China Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.5.3 Japan Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.5.6 India Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.7.3 Israel Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
  6.7.5 UAE Melanoma Diagnostics and Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.1.4 Abbott Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Agilent Technologies
  7.2.1 Agilent Technologies Corporate Summary
  7.2.2 Agilent Technologies Business Overview
  7.2.3 Agilent Technologies Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.2.4 Agilent Technologies Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Agilent Technologies Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.3.4 AstraZeneca Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.4.4 Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Eli Lilly
  7.5.1 Eli Lilly Corporate Summary
  7.5.2 Eli Lilly Business Overview
  7.5.3 Eli Lilly Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.5.4 Eli Lilly Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.6.4 GlaxoSmithKline Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.7.4 Merck Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.8.4 Novartis Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.9.4 Pfizer Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 Qiagen
  7.10.1 Qiagen Corporate Summary
  7.10.2 Qiagen Business Overview
  7.10.3 Qiagen Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.10.4 Qiagen Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Qiagen Key News
7.11 Roche
  7.11.1 Roche Corporate Summary
  7.11.2 Roche Business Overview
  7.11.3 Roche Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.11.4 Roche Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Roche Key News
7.12 Sanofi
  7.12.1 Sanofi Corporate Summary
  7.12.2 Sanofi Business Overview
  7.12.3 Sanofi Melanoma Diagnostics and Therapeutics Major Product Offerings
  7.12.4 Sanofi Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Melanoma Diagnostics and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Melanoma Diagnostics and Therapeutics Market Drivers in Global Market
Table 3. Melanoma Diagnostics and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Melanoma Diagnostics and Therapeutics in Global Market
Table 5. Top Melanoma Diagnostics and Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Melanoma Diagnostics and Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Melanoma Diagnostics and Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Melanoma Diagnostics and Therapeutics Product Type
Table 9. List of Global Tier 1 Melanoma Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Melanoma Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Melanoma Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Melanoma Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Melanoma Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Melanoma Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Melanoma Diagnostics and Therapeutics Product Offerings
Table 32. Abbott Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Agilent Technologies Corporate Summary
Table 34. Agilent Technologies Melanoma Diagnostics and Therapeutics Product Offerings
Table 35. Agilent Technologies Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Melanoma Diagnostics and Therapeutics Product Offerings
Table 38. AstraZeneca Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Product Offerings
Table 41. Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Melanoma Diagnostics and Therapeutics Product Offerings
Table 44. Eli Lilly Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Melanoma Diagnostics and Therapeutics Product Offerings
Table 47. GlaxoSmithKline Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Melanoma Diagnostics and Therapeutics Product Offerings
Table 50. Merck Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Melanoma Diagnostics and Therapeutics Product Offerings
Table 53. Novartis Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Melanoma Diagnostics and Therapeutics Product Offerings
Table 56. Pfizer Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Qiagen Corporate Summary
Table 58. Qiagen Melanoma Diagnostics and Therapeutics Product Offerings
Table 59. Qiagen Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Roche Corporate Summary
Table 61. Roche Melanoma Diagnostics and Therapeutics Product Offerings
Table 62. Roche Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Sanofi Corporate Summary
Table 64. Sanofi Melanoma Diagnostics and Therapeutics Product Offerings
Table 65. Sanofi Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Melanoma Diagnostics and Therapeutics Segment by Type in 2021
Figure 2. Melanoma Diagnostics and Therapeutics Segment by Application in 2021
Figure 3. Global Melanoma Diagnostics and Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Melanoma Diagnostics and Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Melanoma Diagnostics and Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Melanoma Diagnostics and Therapeutics Revenue in 2021
Figure 8. By Type - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Agilent Technologies Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Qiagen Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Roche Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sanofi Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)